under the auspices of Kidney Cancer Association
19-20 July 2019, St. Petersburg, urtyard Marriott Pushkin
Friday, July 19, 2019
10:00-11:30 – RUSSCO junior session
Chairs:
M. Volkova (Moscow) – P. Borisov (St. Petersburg)
Case discussion
11:40-12:40 – BMS satellite symposium
13:00-14:00 – Welcome session
Chairs:
Axel Bex (London) – Christopher Wood (Houston) – I. Tsimafeyeu (Moscow)
13:00-13:05 – Aims of Kidney Cancer Association
13:05-13:20 – Greeting from the Association for the study of kidney cancer. Aims and objectives of the Association
13:20-13:50 – Opening lecture: How Will the Standard of Care Change after Receiving the Results of the SURTIME and CARMENA Surgical Trials?
Axel Bex, Royal Free London NHS Foundation Trust, London, UK
13:50-14:00 – Questions and Answers
14:10-16:45 – Session 1. Access to Cancer Care for Renal Cell Carcinoma Patients in the Eurasian Economic Union States
Chairs:
A. Kaprin (Moscow) – D. Kaydarova (Almaty) – S. Krasny (Minsk)
14:10-14:30 – Morbidity and Mortality in Russia. Healthcare Services
A. Kaprin (Moscow)
14:30-14:35 – Questions and Answers
14:35-14:55 – Morbidity and Mortality in Kazakhstan. Healthcare Services
D. Kaydarova (Almaty)
14:55-15:00 – Questions and Answers
15:00-15:20 – Morbidity and Mortality in Belarus. Healthcare Services
S. Krasny (Minsk)
15:20-15:25 – Questions and Answers
15:25-16:15 – The Results of the RENSUR3 Registry Study: Overall Survival and Treatment Paradigm of 1094 Patients with Metastatic Renal Cell Carcinoma:
15:25-15:35 – in Russia
L. Vladimirova (Rostov-on-Don)
15:35-15:45 – in Kazakhstan
О. Shatkovskaya (Almaty)
15:45-15:55 – in Belarus
S. Krasny (Minsk)
15:55-16:00 – Questions and Answers
16:00-16:15 – Discussion of Study RENSUR3 Results
O. Gladkov (Chelyabinsk)
16:15-16:40 – How to Increase Life Expectancy of Patients in the Third World Countries When the Resources Are Limited?
I. Tsimafeyeu (Moscow)
16:40-16:45 – Questions and Answers
17:00-18:00 – Eisai satellite symposium
18:00 – Dinner
Saturday, 20 July, 2019
10:00-10:50 – Session 2. Morphological Diagnostics of Renal Cell Carcinoma. Pathologist and Clinician
Chairs:
G. Raskin (St. Petersburg) – A. Nosov (St. Petersburg)
10:00-10:20 – What Would a Pathologist Say to a Clinician? (Pathologist)
G. Raskin (St. Petersburg)
10:20-10:40 – What Questions Would a Clinician Like to Ask a Pathologist? (Oncologist)
A. Semenov (Ivanovo)
10:40-10:50 – Discussion
11:00-12:10 – Panel discussion
Сhair and moderator:
Christopher Wood (Houston)
12:25-13:35 – Session 3. Practical Guidelines on Localized and Locally Advanced Renal Cell Carcinoma Treatment
Chairs:
V. Matveev (Moscow) – S. Krasny (Minsk) – О. Shatkovskaya (Almaty)
12:25-12:35 – ESMO Guidelines 2019
Axel Bex (London)
12:35-13:20 – Issues to Be Addressed (includes interactive voting):
12:35-12:50 – Whether Radical or Partial Nephrectomy Should Be Selected for Patients with Т1b Cancer?
V. Matveev (Moscow)
12:50-13:05 – Whether Stereotactic Radiotherapy or Ablation Should Be Selected for Patients with Localized Cancer Who Are not Candidates for Surgery?
P. Borisov (St. Petersburg)
13:05-13:20 – Whether or not Sutinib Should Be Selected as Adjuvant Treatment?
N. Kislov (Yaroslavl)
13:20-13:35 – Views of the Chairs. Discussion
13:50-14:50 – Pfizer satellite symposium
14:50-15:30 – Lunch
15:30-16:55 – Session 4. First Line Therapy in Metastatic Renal Cell Carcinoma. New Treatment Approaches
Chairs:
B. Alexeev (Moscow) – R. Gafanov (Moscow) – L. Vladimirova (Rostov-on-Don)
15:30-15:50 – Combination of Nivolumab and Ipilimumab
V. Matveev (Moscow)
15:50-15:53 – Questions and Answers
15:53-16:13 – Combination of Avelumab and Axitinib
B. Alexeev (Moscow)
16:13-16:16 – Questions and Answers
16:16-16:36 – Combination of Pembrolizumab and Axitinib
R. Gafanov (Moscow)
16:36-16:39 – Questions and Answers
16:39-16:55 – How will the First-Line Treatment Selection Algorithm Change?
B. Alexeev (Moscow)
16:55-17:10 – Coffee-break
17:10-17:45 – Lecture «Managing Progression with Sequential Therapy»
M. Volkova (Moscow)
Chair: I. Tsimafeyeu (Moscow)
18:30-21:30 – Dinner
